文献速递乳腺病理细胞病理与分子病理

TRPS1在乳腺与非乳腺转移性肿瘤中的免疫组化表达

Trichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Müllerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohistochemistry with cytology cell block specimens.
PubMed 文献 · Cancer Cytopathol · 2024-09-12

本研究用细胞块免疫组化评估TRPS1(克隆EPR16171)鉴别转移性乳腺来源的敏感性与特异性,共160例标本含127例FNA和33例积液。TRPS1在转移性乳腺癌阳性率96%,非乳腺转移瘤26.2%;敏感性96.22%、特异性72.89%。非乳腺肿瘤平均H评分显著低于乳腺癌。

要点

  • TRPS1对转移性乳腺癌敏感性高(96.22%),但特异性较低(72.89%)。
  • 非乳腺肿瘤中TRPS1阳性率26.2%,可导致来源误判。
  • 转移性乳腺癌平均H评分247.35,显著高于非乳腺肿瘤。

核心结论

  • TRPS1整体敏感性高但特异性较低,因其在非乳腺肿瘤中也有表达。

研究设计与样本

  • 细胞块免疫组化研究,共160例标本,含127例细针穿刺和33例积液标本。

主要发现

  • 转移性乳腺癌TRPS1阳性51/53(96%),非乳腺转移瘤阳性28/107(26.2%)。
  • 转移性乳腺癌平均H评分247.35,Müllerian为45.36,肺为8.4,胃肠为5.88。
  • TRPS1鉴别乳腺来源的敏感性96.22%、特异性72.89%。

关键数值与推荐

  • H评分≥10判为阳性,评分范围为0-300。

临床怎么用

  • 需认识TRPS1在转移性乳腺与非乳腺肿瘤中的广泛表达,避免误判器官来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trichorhinophalangeal syndrome 1 (TRPS1) expression in primary breast and other solid tumors has been investigated but its role as a marker in metastatic tumors is unclear. The objective of this study was to evaluate the sensitivity and specificity of TRPS1 as a breast cancer immunomarker in metastatic tumors that originated from breast, Müllerian, lung, gastrointestinal (GI), and pancreatic primary tumors with cell blocks from fine-needle aspiration (FNA) and effusion specimens. METHODS: Cell blocks were immunostained with anti-TRPS1 monoclonal antibody (clone EPR16171). Histochemical scores (H scores) (proportion × intensity; range, 0-300) were assigned; H scores of ≥10 were considered positive. Overall, 160 specimens were examined, including 127 FNAs (35 breast, 25 Müllerian, 36 lung, and 31 GI and pancreatic carcinomas) and 33 effusion specimens (18 breast, 12 Müllerian, one lung, and two GI carcinomas). RESULTS: TRPS1 was positive in 51 of 53 (96%) metastatic breast carcinomas and in 28 of 107 (26.2%) nonbreast metastatic tumors. Metastatic breast carcinoma showed the highest mean H score of 247.35, compared to 45.36 in Müllerian, 8.4 in lung, and 5.88 in GI tumors. The sensitivity and specificity of TRPS1 for identifying a breast origin in metastatic tumors was 96.22% and 72.89%, respectively. CONCLUSIONS: Despite high overall sensitivity, TRPS1 showed lower specificity as a breast immunomarker because of its expression in nonbreast tumors. The mean H score in nonbreast tumors was significantly lower than in metastatic breast tumors. It is important to recognize the broad range of expression of TRPS1 in metastatic breast and nonbreast tumors to avoid an incorrect determination of a metastatic tumor's organ of origin.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Donthi D, Gan Q, Ding QQ, et al. Trichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Müllerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohistochemistry with cytology cell block specimens. Cancer Cytopathol. 2024. PMID: 39264831. doi:10.1002/cncy.22901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。